男性年龄增长与特发性不孕IVF/ICSI活产几率降低相关
这项回顾性队列研究分析1992至2017年澳大利亚Monash IVF的2425个特发性不孕周期,发现校正女性年龄后,男性年龄每增加1岁,活产OR为0.96(95%CI 0.94-0.98),临床妊娠OR为0.97(95%CI 0.96-0.99),流产OR为1.05(95%CI 1.01-1.08)。
要点
- 男性年龄每增加1岁,活产几率降低(OR 0.96,95%CI 0.94-0.98)。
- 男性年龄每增加1岁,临床妊娠几率降低(OR 0.97,95%CI 0.96-0.99)。
- 男性年龄每增加1岁,流产几率升高(OR 1.05,95%CI 1.01-1.08)。
核心结论
- 在特发性不孕夫妇中,男性年龄增长与IVF/ICSI临床结局负相关,且独立于女性年龄。
研究设计与样本
- 回顾性队列研究,分析澳大利亚Monash IVF 1992至2017年间24 411个IVF/ICSI周期中筛选出的2425个特发性不孕周期。
- 纳入男性伴侣为正常精子的原发性或继发性不孕夫妇,排除女性子宫内膜异位症、输卵管因素、多囊卵巢综合征、卵巢过度刺激综合征、 poor responders(≤3枚成熟卵母细胞)及获卵数>15枚或使用冷冻配子的周期。
- 采用二分类多水平logistic回归模型,控制混杂因素后分析男性年龄和女性年龄对临床结局的影响,年龄作为连续变量和分类变量(男性:<40、40-44、45-49、50-54、≥55岁;女性:<30、30-34、35-39、≥40岁)进行分析。
主要发现
- 男性年龄和女性年龄对活产均有负面影响,每增加1岁的OR分别为:男性OR 0.96(95%CI 0.94-0.98),女性OR 0.90(95%CI 0.88-0.93),P<0.001。
- 男性年龄与治疗类型(IVF/ICSI)、胚胎移植日(第3天/第5天)及女性年龄的交互作用与结局无显著关联(P>0.05)。
- 临床妊娠几率随年龄增长显著降低:男性OR 0.97(95%CI 0.96-0.99),女性OR 0.92(95%CI 0.89-0.94),P<0.001;流产几率随年龄增长升高:男性OR 1.05(95%CI 1.01-1.08),P=0.002;女性OR 1.11(95%CI 1.05-1.18),P<0.001。
- 周期数越多与更差结局相关(临床妊娠OR 0.96,95%CI 0.93-0.99,P=0.03;活产OR 0.96,95%CI 0.92-0.99,P=0.023);授精卵母细胞数越多与更好结局相关(临床妊娠OR 1.06,95%CI 1.03-1.06,P<0.001;活产OR 1.07,95%CI 1.04-1.11,P<0.001)。
- 按年龄分类分析显示,临床结局随男性年龄增长逐渐恶化,与男性<40岁相比,男性>50岁的活产和临床妊娠结局显著更差(P<0.05)。
关键数值与推荐
- 男性年龄每增加1岁,活产OR 0.96(95%CI 0.94-0.98);女性年龄每增加1岁,活产OR 0.90(95%CI 0.88-0.93),P<0.001。
- 男性年龄每增加1岁,临床妊娠OR 0.97(95%CI 0.96-0.99);女性年龄每增加1岁,临床妊娠OR 0.92(95%CI 0.89-0.94),P<0.001。
- 男性年龄每增加1岁,流产OR 1.05(95%CI 1.01-1.08),P=0.002;女性年龄每增加1岁,流产OR 1.11(95%CI 1.05-1.18),P<0.001。
- 与男性<40岁相比,男性>50岁的活产和临床妊娠结局显著更差(P<0.05)。
临床怎么用
- 作者认为,本研究为特发性不孕夫妇的咨询提供了信息。
局限性
- 本研究仅限于所纳入的混杂因素信息。
- 由于严格的选择标准,研究结果推广到更广泛人群可能受限。
- 将连续变量年龄分类处理可能潜在导致残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is male age associated with the clinical outcomes of IVF/ICSI cycles for idiopathic infertility after adjustment for female age? SUMMARY ANSWER: Male ageing is negatively associated with clinical IVF/ICSI outcomes in couples with idiopathic infertility independent of female age. WHAT IS KNOWN ALREADY: The effect of male age on the outcomes of infertility treatments is controversial and poorly explored. In contrast, fertility is known to decline significantly with female age beyond the mid-30s, and reduced oocyte quality plays an important role. The negative effect of male age on sperm quality is largely associated with an increasing susceptibility to sperm DNA damage. Although increasing maternal age has been linked with poorer oocyte quality, studies on the effect of male age have disregarded the need to control for female age making it difficult to define clearly the role of male age in infertile couples. STUDY DESIGN, SIZE, DURATION: This retrospective cohort study analysed 2425 cycles of couples with idiopathic infertility selected from a total of 24 411 IVF/ICSI cycles performed at Monash IVF in Australia between 1992 and 2017. The primary outcome was live birth and secondary outcomes were clinical pregnancy and miscarriage. PARTICIPANTS/MATERIALS, SETTING, METHODS: Couples with primary/secondary infertility who underwent IVF/ICSI cycles with male partners classified as normozoospermic were selected (inclusion criteria). Couples in which the female partner had endometriosis, tubal factors, polycystic ovarian syndrome, ovarian hyperstimulation syndrome, poor responders (≤3 mature oocytes retrieved) and couples with more than 15 cumulus oocyte complexes retrieved or who used cryopreserved gametes were excluded. Binary logistic multilevel modelling was used to identify the effect of male age and female age on clinical outcomes after controlling for confounding factors. Male age and female age were examined as continuous and categorical (male age: <40, 40-44, 45-49, 50-54, ≥55; female age:<30, 30-34, 35-39, ≥40) predictors. MAIN RESULTS AND THE ROLE OF CHANCE: There was a negative effect of male age and female age on live birth as odds ratios (OR) with 95% CI for each additional year of age (OR-male age: 0.96 [0.94-0.98]; OR-female age: 0.90 [0.88-0.93] P < 0.001). Potential interactions with male age such as type of treatment (IVF/ICSI), embryo transfer day (Day 3/Day 5) and female age did not have significant associations with outcomes (P > 0.05). Secondary outcomes showed a significant reduction in the odds of clinical pregnancy (OR-male age: 0.97 [0.96-0.99]; OR-female age: 0.92 [0.89-0.94] P < 0.001) and an increase in the odds of miscarriage with older age: male age (OR: 1.05 [1.01-1.08]; P = 0.002); female age (OR: 1.11 [1.05-1.18]; P < 0.001). Worse outcomes were associated with more cycles (clinical pregnancy-OR: 0.96 [0.93-0.99] P = 0.03; live birth-OR: 0.96 [0.92-0.99] P = 0.023) while more inseminated oocytes were associated with better outcomes (clinical pregnancy-OR: 1.06 [1.03-1.06] P < 0.001; live birth-OR: 1.07 [1.04-1.11] P < 0.001). Analyses for age categories showed a gradual worsening of clinical outcomes with increasing male age, with a significantly worse live birth and clinical pregnancy outcomes in males aged older than 50 years compared to males younger than 40 years (P < 0.05). LIMITATIONS, REASONS FOR CAUTION: This study is limited to the information on confounding factors included. The study may also be limited in its generalizability to a wider population due the strict selection criteria. Age as a category could potentially result in residual confounding due to categorizing a continuous variable. WIDER IMPLICATIONS OF THE FINDINGS: This study provides information for counselling of couples with idiopathic infertility. STUDY FUNDING/COMPETING INTEREST(S): Funded by the Education Program in Reproduction and Development, Department of Obstetrics and Gynaecology, Monash University. None of the authors has any conflict of interest to report. TRIAL REGISTRATION NUMBER: N/A.
引用
- Horta F, Vollenhoven B, Healey M, et al. Male ageing is negatively associated with the chance of live birth in IVF/ICSI cycles for idiopathic infertility. Hum Reprod. 2019. PMID: 31769477. doi:10.1093/humrep/dez223
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。